Product Description: Tripelennamine hydrochloride, an ethylenediamine derivative, is a potent histamine H1-receptor antagonist. Tripelennamine hydrochloride lessens the allergic response of the organism caused by histamine. Tripelennamine hydrochloride can be used for the research of rhinitis, conjunctivitis, and allergic and anaphylactic reactions[1][2][3].
Applications: COVID-19-immunoregulation
Formula: C16H22ClN3
References: [1]Manohar M, et al. H1-receptor antagonist, tripelennamine, does not affect arterial hypoxemia in exercising Thoroughbreds. J Appl Physiol. 2002 Apr;92(4):1515-23./[2]Wasfi IA, et al. Comparative disposition of tripelennamine in horses and camels after intravenous administration. J Vet Pharmacol Ther. 2000 Jun;23(3):145-52./[3]Yeh SY, et al. The pharmacokinetics of pentazocine and tripelennamine. Clin Pharmacol Ther. 1986 Jun;39(6):669-76.
CAS Number: 154-69-8
Molecular Weight: 291.82
Compound Purity: 99.81
Research Area: Inflammation/Immunology; Endocrinology
Solubility: DMSO : 25 mg/mL (ultrasonic)/H2O : 100 mg/mL (ultrasonic)
Target: Endogenous Metabolite;Histamine Receptor
Deutsch
English
